Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1971 3
1973 3
1974 6
1975 11
1976 7
1977 7
1978 15
1979 13
1980 19
1981 29
1982 29
1983 32
1984 47
1985 38
1986 52
1987 51
1988 45
1989 70
1990 88
1991 85
1992 77
1993 102
1994 111
1995 120
1996 146
1997 133
1998 149
1999 168
2000 165
2001 174
2002 170
2003 219
2004 212
2005 242
2006 226
2007 258
2008 292
2009 278
2010 318
2011 426
2012 450
2013 446
2014 467
2015 510
2016 457
2017 447
2018 446
2019 487
2020 505
2021 479
2022 440
2023 415
2024 208

Text availability

Article attribute

Article type

Publication date

Search Results

9,217 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Carcinoma in the Liver"
Page 1
Liver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria: A Systematic Review and Meta-analysis.
Shin SW, Ahn KS, Kim SW, Kim TS, Kim YH, Kang KJ. Shin SW, et al. Ann Surg. 2021 Apr 1;273(4):656-666. doi: 10.1097/SLA.0000000000004350. Ann Surg. 2021. PMID: 33074898
OBJECTIVE: To compare the oncologic outcomes of liver resection (LR) and local ablation therapies for HCC. SUMMARY OF BACKGROUND DATA: Although several studies have compared LR and local ablation therapies, the optimal treatment of choice for HCC within the Milan criteria …
OBJECTIVE: To compare the oncologic outcomes of liver resection (LR) and local ablation therapies for HCC. SUMMARY OF BACKGROUND DATA …
Hepatic tumours and radiotherapy.
Rio E, Mornex F, Maingon P, Peiffert D, Parent L. Rio E, et al. Cancer Radiother. 2022 Feb-Apr;26(1-2):266-271. doi: 10.1016/j.canrad.2021.08.013. Epub 2021 Dec 23. Cancer Radiother. 2022. PMID: 34953707
Recent technological progress led to develop the concept of focused liver radiation therapy. We must distinguish primary and secondary tumours, as the indications are restricted and must be discussed as an alternative to surgical or medical treatments. ...Stereotact …
Recent technological progress led to develop the concept of focused liver radiation therapy. We must distinguish primary and secon …
Imaging of Fontan-Associated Liver Disease.
Brown MJ, Kolbe AB, Hull NC, Hilscher M, Kamath PS, Yalon M, Gu CN, Amawi ADT, Venkatesh SK, Wells ML. Brown MJ, et al. J Comput Assist Tomogr. 2024 Jan-Feb 01;48(1):1-11. doi: 10.1097/RCT.0000000000001533. Epub 2023 Aug 10. J Comput Assist Tomogr. 2024. PMID: 37574655
Surgical advances have led to a growing number of patients surviving into adulthood. Fontan-associated liver disease (FALD) encompasses a spectrum of pathologic liver changes that occur secondary to altered physiology including congestion, fibrosis, and the d …
Surgical advances have led to a growing number of patients surviving into adulthood. Fontan-associated liver disease (FALD) encompass …
The ins and outs of liver imaging.
O'Neill EK, Cogley JR, Miller FH. O'Neill EK, et al. Clin Liver Dis. 2015 Feb;19(1):99-121. doi: 10.1016/j.cld.2014.09.006. Epub 2014 Oct 29. Clin Liver Dis. 2015. PMID: 25454299 Review.
Liver imaging surveillance in patients with cirrhosis may allow for detection of hepatocellular carcinoma at an earlier stage, and therefore may improve outcome. This article reviews the different imaging modalities used to evaluate the liver and focal benign …
Liver imaging surveillance in patients with cirrhosis may allow for detection of hepatocellular carcinoma at an earlier stage, …
Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets.
Strathearn LS, Stepanov AI, Font-Burgada J. Strathearn LS, et al. Nutrients. 2020 Mar 27;12(4):933. doi: 10.3390/nu12040933. Nutrients. 2020. PMID: 32230953 Free PMC article. Review.
The liver plays an outsized role in oncology. Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease. ...Here we review how Westernized high-fat diets and excessive alcohol intake …
The liver plays an outsized role in oncology. Liver tumors are one of the most frequently found tumors in cancer patients and …
New Insights in the Setting of Transplant Oncology.
Quaresima S, Melandro F, Giovanardi F, Shah K, De Peppo V, Mennini G, Ghinolfi D, Limkemann A, Pawlik TM, Lai Q. Quaresima S, et al. Medicina (Kaunas). 2023 Mar 14;59(3):568. doi: 10.3390/medicina59030568. Medicina (Kaunas). 2023. PMID: 36984569 Free PMC article. Review.
Background and Objectives: Liver transplantation (LT) is the best strategy for curing several primary and secondary hepatic malignancies. ...This paper aims to review the most recent developments in the setting of LT oncology, with particular attention to LT for unr …
Background and Objectives: Liver transplantation (LT) is the best strategy for curing several primary and secondary hepatic ma …
Cholangiocarcinoma: has there been any progress?
Meza-Junco J, Montano-Loza AJ, Ma M, Wong W, Sawyer MB, Bain VG. Meza-Junco J, et al. Can J Gastroenterol. 2010 Jan;24(1):52-7. doi: 10.1155/2010/704759. Can J Gastroenterol. 2010. PMID: 20186357 Free PMC article. Review.
Recently, neoadjuvant chemoradiation in combination with liver transplantation for highly selected patients with cholangiocarcinoma has shown impressive results, with five-year survival rates at approximately 76% to 82%--similar to other standard indications for liver …
Recently, neoadjuvant chemoradiation in combination with liver transplantation for highly selected patients with cholangiocarcinoma h …
Management of Recurrent HCC After Liver Transplantation.
Sarici B, Isik B, Yilmaz S. Sarici B, et al. J Gastrointest Cancer. 2020 Dec;51(4):1197-1199. doi: 10.1007/s12029-020-00498-6. J Gastrointest Cancer. 2020. PMID: 32839944 Review.
BACKGROUND: Liver transplantation is the best treatment option for hepatocellular carcinoma (HCC). ...
BACKGROUND: Liver transplantation is the best treatment option for hepatocellular carcinoma (HCC). ...
Primary and metastatic liver cancer.
Groen KA. Groen KA. Semin Oncol Nurs. 1999 Feb;15(1):48-57. doi: 10.1016/s0749-2081(99)80039-4. Semin Oncol Nurs. 1999. PMID: 10074657 Free article. Review.
OBJECTIVES: To review liver physiology, the disease process, diagnostic tests, and current treatment options for primary and metastatic liver cancer. ...IMPLICATIONS FOR NURSING PRACTICE: Understanding and knowledge of the disease process and treatment modali …
OBJECTIVES: To review liver physiology, the disease process, diagnostic tests, and current treatment options for primary and metas …
Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.
Sikorska K, Bernat A, Wroblewska A. Sikorska K, et al. Hepatobiliary Pancreat Dis Int. 2016 Oct;15(5):461-479. doi: 10.1016/s1499-3872(16)60135-2. Hepatobiliary Pancreat Dis Int. 2016. PMID: 27733315 Review.
Excessive accumulation of iron is an important risk factor in liver disease progression to cirrhosis and hepatocellular carcinoma. Here, we review the literature on the molecular pathogenesis of iron overload and its clinical consequences in chronic liver dis …
Excessive accumulation of iron is an important risk factor in liver disease progression to cirrhosis and hepatocellular carcinoma …
9,217 results